Trials / Conditions / Mixed Lineage Acute Leukemia
Mixed Lineage Acute Leukemia
3 registered clinical trials studyying Mixed Lineage Acute Leukemia — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation NCT04065399 | Syndax Pharmaceuticals | Phase 1 / Phase 2 |
| Recruiting | First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia NCT04067336 | Kura Oncology, Inc. | Phase 1 / Phase 2 |
| Terminated | Bortezomib and Vorinostat in Younger Patients With Refractory or Relapsed MLL Rearranged Hematologic Malignanc NCT02419755 | St. Jude Children's Research Hospital | Phase 2 |